Liberty Health Sciences is an investor and operator in the medical cannabis industry. It has just opened its 28th dispensary and plans to strategically open three more dispensaries by the end of February 2021. As a state-licensed MMTC, it has the necessary state approval to offer its products to patients.
Investor & Operator In The Medical Cannabis Market
As an investor in the medical cannabis industry, you’re gaining exposure to one of the fastest growing markets in the world. Liberty Health Sciences is an investor and operator in Florida that has already gained a key operating license. The company is backed by Aphria, a Canadian company that has invested $25 million in Liberty. The company produces pharmaceutical-grade cannabis and intends to deliver it to patients in the United States and Canada.
The company acquired the William Noyes Webster Foundation on March 28, 2018, and has partnered with 10 other companies in the industry. They recently partnered with vcc brands and the Udaan B2B marketplace for small and medium businesses in India. The company has invested in cannabis technology that can be used to develop medical cannabis products. It also has a growing team of professionals who have a background in the pharmaceutical industry.
Exclusive Management Agreement with Chestnut Hill Tree Farm
Liberty Health Sciences, based in Toronto, has a vertically integrated medical marijuana business in Florida. The company plans to expand its production by 33-fold in the next two years. As an investor, you can look at the company’s financials to get a good idea of its business model. Its shareholders include Aphria and Chestnut Tree Hill.
While Liberty’s focus is on Florida, it is also expanding its presence in key U.S. markets, including Arizona. For example, it recently signed an exclusive management agreement with Chestnut Hill Tree Farm, LLC, which is a Florida-based medical cannabis nursery. The Florida Department of Health has licensed Chestnut Hill Tree Farm, LLC as an operator, and it currently has one of seven medical cannabis licenses. The company expects to expand its Florida presence in the coming years.
Currently, Liberty Health is in the process of expanding its Florida operations and expects to open seven more dispensaries by the end of February. By then, the company will have 14 dispensaries in Florida, including Miami, Fort Lauderdale, and Gainesville. However, this expansion is subject to Florida Department of Health approval.
It Recently Opened its 28th Dispensary in Lake City
Liberty Health Sciences, a Florida licensed medical marijuana provider, recently opened its 28th dispensary in the city of Lake City, Fla. The dispensary is designed to offer patients high-quality wellness products. Products are available in multiple brands, including Aphria, Papa’s Herb, Riff, and Mary’s Medicinals. Customers can choose to pick up their products in person or have them delivered.
The two companies have plans to expand by opening more dispensaries and expanding their current facilities. They also plan to acquire more dispensaries in states where cannabis is legal. The company has pending acquisitions in Arizona, Pennsylvania, and Ohio. It is also planning to expand its cultivation capabilities.
Besides being located in Lake City, the dispensaries in other Florida cities are located near Lake County and the Miami area. The dispensaries will provide THC and CBD products that can relieve inflammation, cancer, and pain. Patients will also find tinctures in a variety of ratios, pre-rolls, vape products, and concentrates.
It Plans to Strategically Open 3 More Dispensaries
Liberty Health Sciences Inc. (LHSI) has recently opened its 28th retail location in Lake City, Florida. The company’s mission is to offer premium-quality medical marijuana products while providing education and support services to consumers. The company has a large customer base, with 2.7 million people in South Florida. Customers know they can depend on Liberty Health Sciences to provide only the highest-quality products. The dispensary chain is also committed to offering the most trusted brand names in medical marijuana.
Chestnut Hill, however, has yet to open a dispensary. That is because the company must deliver all product to patients. Nevertheless, the company’s goal is to become a dominant player in the international medical cannabis market. For this, it has retained transactional advisory services from the Delavaco Group.
It is Preparing to Expand its Production Facilities
The company is also preparing to expand its production facilities. It plans to add an expanded cultivation space and a state-of-the-art research lab. This expansion will almost double the company’s extraction capacity. The new facility will also expand Liberty’s product line. The company is also preparing for growth in other markets.
While Liberty Health has experienced stagnant growth in recent years, the Florida market has continued to grow. However, the company’s supply chain has continued to struggle. It has not disclosed the cause of its flower sales slump. The company adopted Seed Junky genetics in August, but has not disclosed what this change in genetics has done to the company’s flower sales.
Ayr and Liberty Health Sciences have reached an agreement on an investor rights agreement. The agreement calls for Ayr to designate two directors to the company’s board. In addition, Ayr maintains a minimum of 10% of Liberty’s common shares.
It is a State-Licensed MMTC
Liberty Health Sciences is a Florida-based cannabis company that sells state-licensed medical marijuana products. Its mission is to provide patients with a higher quality of life and to give them a sense of freedom. To qualify for a medical marijuana certificate, patients must meet specific criteria set by the Florida Department of Health Office of Medical Marijuana Use. Liberty Health Sciences is one of a select number of MMTCs, or medical marijuana treatment centers, that are licensed by the state to provide marijuana to qualified patients.
Liberty Health Sciences is a state-license MMTC with many open dispensary locations throughout Florida. The company has gone through many changes since its early days as one of the first cannabis companies to operate in the state. Since then, it has introduced a number of top brands, including Zentient, Mary’s Medicinals, and Papa’s Herb. Today, it offers a wide range of products, including flower, pre-rolls, and oils.
It Aims to Provide a Friendly Environment for Patients
The company is a subsidiary of DFMMJ Investments, a Canadian medical cannabis company. Its dispensaries are located in Tampa, Port St. Lucie, and St. Petersburg, among other Florida cities. The company is committed to providing accessible and high-quality medical marijuana to patients, and Liberty Health Sciences aims to provide a friendly, professional environment for patients.
In Florida, the DOH plans to issue 15 new MMTC licenses in the next six months, bringing the total to 41. The state’s marijuana industry already generates over $1 billion in sales annually. It currently has 22 MMTCs, with the number expected to grow to more than 620,000 patients. As the number of patients increases, more licenses are expected to be issued.
It has An in-License Agreement with The Werc Shop
The in-license agreement with The Werc Shop enables Liberty Health Sciences to develop and manufacture standardized medical cannabis products in Florida. The Werc Shop is a scientific consulting group that specializes in cannabis terpene analysis and formulations. Its technology allows the company to create medical cannabis products that are both effective and safe.
Liberty currently operates 25 dispensaries throughout Florida, and is implementing health measures to protect its patients and employees. The company also has lease agreements for another 10 locations and is in negotiations for 10 more. In addition, the company has received approval from the Florida Department of Health for its LHS360 Innovative Campus, which includes 190,000 square feet of cultivation and manufacturing space. For more health-related articles visit On Trending News